Literature DB >> 6235460

Delivery of active hexosaminidase across the blood-brain barrier in rats.

E A Neuwelt, J A Barranger, M A Pagel, J M Quirk, R O Brady, E P Frenkel.   

Abstract

The ability to deliver enzymatically active human hexosaminidase A across the blood-brain barrier and into brain cells of the normal rat was examined. Following osmotic blood-brain barrier modification in the rat, intraarterially administered human hexosaminidase A and B were shown to cross the barrier and enter brain cells. Subcellular fractionation studies demonstrated that most of the human enzyme delivered across the barrier was functionally active and appeared to be inside a subcellular organelle. These studies provide evidence that blood-brain barrier modification permits delivery of functionally active hexosaminidase A into subcellular organelles consistent with that known to be the appropriate site of physiologic activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235460     DOI: 10.1212/wnl.34.8.1012

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  Gene transfer approaches to the lysosomal storage disorders.

Authors:  J A Barranger; E O Rice; W P Swaney
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.

Authors:  R M Shull; N E Hastings; R R Selcer; J B Jones; J R Smith; W C Cullen; G Constantopoulos
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats.

Authors:  E A Neuwelt; W G Johnson; N K Blank; M A Pagel; C Maslen-McClure; M J McClure; P M Wu
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain.

Authors:  G C Zirzow; O A Sanchez; G J Murray; R O Brady; E H Oldfield
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.